FindTrial
Sign In

Measles, Mumps, and Rubella Virus Vaccine Live

BIOLOGICAL4 trials

Sponsors

Merck Sharp & Dohme LLC, Sanofi Pasteur, a Sanofi Company

Conditions

Diphtheria ImmunisationHaemophilus Influenzae Type b ImmunisationHealthy Volunteers (Meningococcal Infection)Hepatitis B ImmunisationMeaslesMeasles ImmunisationMumpsMumps Immunisation

Phase 2

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)
CompletedNCT00092404
Merck Sharp & Dohme LLCMeasles, Mumps, Rubella +1
Start: 2001-12-31End: 2005-06-30Updated: 2017-03-15
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
CompletedNCT04398706
Sanofi Pasteur, a Sanofi CompanyDiphtheria Immunisation, Haemophilus Influenzae Type b Immunisation, Hepatitis B Immunisation +8
Start: 2020-05-22End: 2023-08-10Updated: 2025-09-08

Phase 3

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico
CompletedNCT03630705
Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers (Meningococcal Infection)
Start: 2018-10-17End: 2022-02-18Updated: 2023-10-19
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
CompletedNCT03691610
Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers (Meningococcal Infection)
Start: 2018-10-04End: 2023-10-20Updated: 2024-06-25

Related Papers

Meningococcal quadrivalent ACYW-TT conjugated vaccine at 6–23 months: phase III study (US/Puerto Rico)
Pediatric Research2026-03-06
Safety and immunogenicity of a 3-dose schedule of a quadrivalent meningococcal tetanus toxoid conjugate vaccine administered concomitantly with routine pediatric vaccines to infants and toddlers: A descriptive randomized study
2026-01-01
Safety and immunogenicity of a 3-dose schedule of a quadrivalent meningococcal tetanus toxoid conjugate vaccine administered concomitantly with routine pediatric vaccines to infants and toddlers: A descriptive randomized study
2026-01-01
Safety and immunogenicity of a 3-dose schedule of a quadrivalent meningococcal tetanus toxoid conjugate vaccine administered concomitantly with routine pediatric vaccines to infants and toddlers: A descriptive randomized study.
2025-12-01
P-662. Phase III, modified double-blind, randomized, parallel group, active-controlled, multi-center study of Meningococcal quadrivalent ACWY conjugated vaccine in infants from 6 through 23 months of age in the United States
Open Forum Infectious Diseases2025-01-29